Richard Mulligan Sana Biotechnology, Inc. (SANA) insider trading activity

Richard Mulligan is of Sana Biotechnology, Inc.. Currently has a direct ownership of 2.7 Million shares of SANA, which is worth approximately $11.5 Million. The most recent transaction as insider was on Sep 25, 2024, when has been sold 150,000 shares (Common Stock) at a price of $3.89 per share, resulting in proceeds of $583,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.7M

n/a 3M change

n/a 12M change

Total Value Held $11.5 Million

Richard Mulligan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 25 2024	SELL Open market or private sale	$583,500 $3.89 p/Share	150,000 Reduced 5.27%	2,698,121 Common Stock
Sep 24 2024	SELL Open market or private sale	$612,000 $4.08 p/Share	150,000 Reduced 5.0%	2,848,121 Common Stock

Also insider at

BIIB

BIOGEN INC. Healthcare

Director

BHC

Bausch Health Companies Inc. Healthcare

Director